Clinical Trials · NCT00528866
Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Radiation Therapy Oncology Group
- Enrollment
- 80
- Start date
- Apr 2008
- Locations
- 70 sites, United States, Canada
- Primary endpoint
- Number of Participants Free From Progression at 3 Years